Diffuse pulmonary lymphangiomatosis treated with bevacizumab

Diffuse pulmonary lymphangiomatosis (DPL) is a rare disease caused by uncontrolled lymphatic vessel proliferation resulting in respiratory dysfunction. Lymphatic vessel growth is influenced by vascular endothelial growth factor (VEGF). It has been shown that bevacizumab, a monoclonal antibody to VEG...

Descripción completa

Detalles Bibliográficos
Autores principales: Onyeforo, Ernest, Barnett, Adrian, Zagami, Debbie, Deller, David, Feather, Iain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260917/
https://www.ncbi.nlm.nih.gov/pubmed/30510764
http://dx.doi.org/10.1002/rcr2.384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260917/
https://www.ncbi.nlm.nih.gov/pubmed/30510764
http://dx.doi.org/10.1002/rcr2.384

Ejemplares similares